FDA Clearance Tracker · K201740
Hydrozid
Last checked: Nov 21, 2026Latest source record: Jul 7, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Jul 7, 2021
Substantially Equivalent
Time to decision
377 days
Received Jun 25, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K201740
- Device name
- Hydrozid
- Applicant
- Medilink A/S
- Applicant location
- Kgs. Lyngby, DK
- Received
- Jun 25, 2020
- Decided
- Jul 7, 2021
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device type
- Unit, Cryosurgical, Accessories (GEH)
- Device class
- Class II
- Regulation
- 21 CFR 878.4350
- Specialty
- General & Plastic Surgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code GEH. The earliest in FDA's data is K760353, decided Oct 29, 1976.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K201740
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Medilink A/S
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
No other decisions since 2015 under this exact applicant name.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.